Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Seliger

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Current Cardiology Reports|August 10, 2020
The Cardiorenal Syndrome: Mechanistic Insights and Prognostication with Soluble BiomarkersStephen Seliger
Research Square|June 17, 2024
Characterizing the Impact of the Covid-19 Pandemic on Adults with Autosomal Dominant Polycystic Kidney Disease: A Cross-Sectional StudyAlok Shetty, Anthony Atalla, Charalett Diggs, et al.
BMC Nephrology|August 23, 2024
Characterizing the impact of the Covid-19 pandemic on adults with autosomal dominant polycystic kidney disease: a cross-sectional studyAlok Shetty, Anthony Atalla, Charalett Diggs, et al.
Nephrology News & Issues|July 8, 2016
Providing supportive care to patients with kidney diseaseJennifer St Clair Russell, Dale Lupu, Stephen Seliger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 11, 2017
Risk for cognitive impairment across 22 measures of cognitive ability in early-stage chronic kidney diseaseRachael V Torres, Merrill F Elias, Stephen Seliger, et al.
Journal of the American Society of Nephrology : JASN|April 27, 2013
Incidence of stroke before and after dialysis initiation in older patientsAnne M Murray, Stephen Seliger, Kamakshi Lakshminarayan, et al.
BMC Nephrology|February 16, 2024
Mortality risk in patients with autosomal dominant polycystic kidney diseaseDeirdre Mladsi, Xiaolei Zhou, Gregory Mader, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2003
Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicityR Graham Barr, Stephen Seliger, Gerald B Appel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 20, 2019
Alterations of Proximal Tubular Secretion in Autosomal Dominant Polycystic Kidney DiseaseKe Wang, Leila R Zelnick, Yan Chen, et al.
BMC Nephrology|October 18, 2022
A disease progression model estimating the benefit of tolvaptan on time to end-stage renal disease for patients with rapidly progressing autosomal dominant polycystic kidney diseaseGregory Mader, Deirdre Mladsi, Myrlene Sanon, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Current Cardiology Reports|August 10, 2020
The Cardiorenal Syndrome: Mechanistic Insights and Prognostication with Soluble BiomarkersStephen Seliger
Research Square|June 17, 2024
Characterizing the Impact of the Covid-19 Pandemic on Adults with Autosomal Dominant Polycystic Kidney Disease: A Cross-Sectional StudyAlok Shetty, Anthony Atalla, Charalett Diggs, et al.
BMC Nephrology|August 23, 2024
Characterizing the impact of the Covid-19 pandemic on adults with autosomal dominant polycystic kidney disease: a cross-sectional studyAlok Shetty, Anthony Atalla, Charalett Diggs, et al.
Nephrology News & Issues|July 8, 2016
Providing supportive care to patients with kidney diseaseJennifer St Clair Russell, Dale Lupu, Stephen Seliger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 11, 2017
Risk for cognitive impairment across 22 measures of cognitive ability in early-stage chronic kidney diseaseRachael V Torres, Merrill F Elias, Stephen Seliger, et al.
Journal of the American Society of Nephrology : JASN|April 27, 2013
Incidence of stroke before and after dialysis initiation in older patientsAnne M Murray, Stephen Seliger, Kamakshi Lakshminarayan, et al.
BMC Nephrology|February 16, 2024
Mortality risk in patients with autosomal dominant polycystic kidney diseaseDeirdre Mladsi, Xiaolei Zhou, Gregory Mader, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2003
Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicityR Graham Barr, Stephen Seliger, Gerald B Appel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 20, 2019
Alterations of Proximal Tubular Secretion in Autosomal Dominant Polycystic Kidney DiseaseKe Wang, Leila R Zelnick, Yan Chen, et al.
BMC Nephrology|October 18, 2022
A disease progression model estimating the benefit of tolvaptan on time to end-stage renal disease for patients with rapidly progressing autosomal dominant polycystic kidney diseaseGregory Mader, Deirdre Mladsi, Myrlene Sanon, et al.
Pageof 5